 David Mathes
Concepts (308)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammaplasty | 23 | 2023 | 71 | 7.800 |
Why?
| | Surgical Flaps | 10 | 2018 | 118 | 3.290 |
Why?
| | Perforator Flap | 7 | 2022 | 19 | 3.160 |
Why?
| | Surgery, Plastic | 5 | 2023 | 29 | 2.380 |
Why?
| | Transplantation Tolerance | 8 | 2016 | 31 | 2.020 |
Why?
| | Skin Transplantation | 9 | 2018 | 58 | 1.980 |
Why?
| | Epigastric Arteries | 9 | 2022 | 15 | 1.740 |
Why?
| | Microsurgery | 8 | 2020 | 64 | 1.740 |
Why?
| | Composite Tissue Allografts | 4 | 2016 | 8 | 1.720 |
Why?
| | Vascularized Composite Allotransplantation | 3 | 2020 | 22 | 1.690 |
Why?
| | Graft Survival | 14 | 2020 | 504 | 1.670 |
Why?
| | Facial Transplantation | 4 | 2014 | 9 | 1.620 |
Why?
| | Graft Rejection | 11 | 2016 | 555 | 1.550 |
Why?
| | Hand Transplantation | 5 | 2011 | 9 | 1.540 |
Why?
| | Free Tissue Flaps | 3 | 2022 | 33 | 1.470 |
Why?
| | Transplantation Chimera | 6 | 2014 | 51 | 1.240 |
Why?
| | Bone Marrow Transplantation | 6 | 2014 | 244 | 1.220 |
Why?
| | Surgical Wound Dehiscence | 2 | 2021 | 19 | 1.200 |
Why?
| | Acellular Dermis | 3 | 2022 | 13 | 1.150 |
Why?
| | Breast Implants | 3 | 2023 | 14 | 1.120 |
Why?
| | Transplantation, Homologous | 14 | 2016 | 415 | 1.110 |
Why?
| | Breast Neoplasms | 9 | 2023 | 1965 | 1.100 |
Why?
| | Immune Tolerance | 7 | 2014 | 334 | 1.090 |
Why?
| | Rectus Abdominis | 3 | 2021 | 12 | 1.080 |
Why?
| | Angiography | 5 | 2022 | 185 | 1.010 |
Why?
| | Breast Implantation | 2 | 2022 | 7 | 0.990 |
Why?
| | Body Dysmorphic Disorders | 1 | 2023 | 6 | 0.950 |
Why?
| | Rhinoplasty | 1 | 2023 | 20 | 0.930 |
Why?
| | Preoperative Care | 5 | 2012 | 332 | 0.900 |
Why?
| | Vascular Surgical Procedures | 2 | 2019 | 262 | 0.870 |
Why?
| | Fat Necrosis | 1 | 2021 | 6 | 0.830 |
Why?
| | Transplant Donor Site | 1 | 2021 | 4 | 0.830 |
Why?
| | Subcutaneous Tissue | 1 | 2021 | 17 | 0.820 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2016 | 540 | 0.810 |
Why?
| | Pressure Ulcer | 2 | 2011 | 33 | 0.770 |
Why?
| | Abdominal Wall | 2 | 2010 | 27 | 0.710 |
Why?
| | Kidney Transplantation | 5 | 2012 | 585 | 0.660 |
Why?
| | Tissue Transplantation | 3 | 2012 | 11 | 0.660 |
Why?
| | Nipples | 1 | 2018 | 6 | 0.650 |
Why?
| | Retrospective Studies | 21 | 2023 | 12978 | 0.620 |
Why?
| | Tomography, X-Ray Computed | 3 | 2012 | 2436 | 0.590 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2016 | 20 | 0.590 |
Why?
| | Tissue and Organ Harvesting | 2 | 2014 | 67 | 0.570 |
Why?
| | Patient Safety | 1 | 2019 | 281 | 0.550 |
Why?
| | Bone Marrow Cells | 1 | 2016 | 273 | 0.540 |
Why?
| | Practice Patterns, Physicians' | 3 | 2023 | 1200 | 0.510 |
Why?
| | Humans | 55 | 2023 | 118972 | 0.510 |
Why?
| | Myocutaneous Flap | 1 | 2014 | 3 | 0.510 |
Why?
| | Groin | 1 | 2014 | 17 | 0.500 |
Why?
| | Perineum | 1 | 2014 | 29 | 0.500 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2014 | 33 | 0.490 |
Why?
| | Pregnancy, Animal | 1 | 2014 | 57 | 0.490 |
Why?
| | Pelvis | 1 | 2014 | 92 | 0.470 |
Why?
| | Dogs | 5 | 2016 | 371 | 0.450 |
Why?
| | Surgical Wound Infection | 4 | 2023 | 251 | 0.450 |
Why?
| | Patient Satisfaction | 2 | 2023 | 610 | 0.450 |
Why?
| | Breast | 2 | 2011 | 140 | 0.440 |
Why?
| | Face | 2 | 2013 | 165 | 0.420 |
Why?
| | Swine, Miniature | 7 | 2014 | 71 | 0.410 |
Why?
| | Attitude of Health Personnel | 2 | 2009 | 992 | 0.410 |
Why?
| | Immunotoxins | 2 | 2023 | 35 | 0.410 |
Why?
| | Lymphoma, T-Cell, Cutaneous | 2 | 2023 | 41 | 0.400 |
Why?
| | Communications Media | 1 | 2011 | 7 | 0.400 |
Why?
| | Female | 31 | 2023 | 61564 | 0.400 |
Why?
| | Computed Tomography Angiography | 2 | 2022 | 81 | 0.400 |
Why?
| | Models, Animal | 3 | 2012 | 363 | 0.390 |
Why?
| | Antibiotic Prophylaxis | 1 | 2012 | 100 | 0.390 |
Why?
| | Swine | 9 | 2014 | 730 | 0.380 |
Why?
| | Diphtheria Toxin | 2 | 2021 | 63 | 0.370 |
Why?
| | Coitus | 1 | 2010 | 28 | 0.370 |
Why?
| | Postoperative Complications | 8 | 2023 | 2235 | 0.370 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2010 | 39 | 0.370 |
Why?
| | Osteomyelitis | 1 | 2011 | 110 | 0.370 |
Why?
| | Ultrasonography, Doppler | 1 | 2010 | 104 | 0.360 |
Why?
| | Internet | 2 | 2011 | 633 | 0.350 |
Why?
| | Facial Injuries | 1 | 2009 | 19 | 0.350 |
Why?
| | Middle Aged | 16 | 2021 | 27617 | 0.340 |
Why?
| | Amputation, Traumatic | 1 | 2009 | 18 | 0.340 |
Why?
| | Traumatology | 1 | 2009 | 24 | 0.340 |
Why?
| | Mastectomy | 4 | 2023 | 124 | 0.340 |
Why?
| | Arteries | 2 | 2013 | 250 | 0.340 |
Why?
| | Hand Injuries | 1 | 2009 | 37 | 0.330 |
Why?
| | Magnetic Resonance Angiography | 1 | 2010 | 210 | 0.330 |
Why?
| | Vagina | 1 | 2010 | 148 | 0.320 |
Why?
| | Follow-Up Studies | 8 | 2021 | 4596 | 0.320 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2008 | 19 | 0.310 |
Why?
| | Thigh | 1 | 2008 | 56 | 0.310 |
Why?
| | Skin Neoplasms | 3 | 2023 | 762 | 0.310 |
Why?
| | Mastectomy, Segmental | 2 | 2017 | 91 | 0.300 |
Why?
| | Cannabis | 2 | 2023 | 382 | 0.290 |
Why?
| | Back | 1 | 2006 | 10 | 0.290 |
Why?
| | Orthopedics | 1 | 2009 | 132 | 0.290 |
Why?
| | Wounds and Injuries | 2 | 2012 | 772 | 0.290 |
Why?
| | Histocompatibility | 3 | 2014 | 27 | 0.260 |
Why?
| | Societies, Medical | 1 | 2009 | 703 | 0.260 |
Why?
| | Transplantation Conditioning | 3 | 2016 | 156 | 0.260 |
Why?
| | Anastomosis, Surgical | 3 | 2020 | 146 | 0.250 |
Why?
| | Animals | 18 | 2023 | 33381 | 0.250 |
Why?
| | Immunosuppressive Agents | 6 | 2014 | 681 | 0.240 |
Why?
| | Fetus | 2 | 2005 | 690 | 0.240 |
Why?
| | Body Contouring | 1 | 2023 | 8 | 0.230 |
Why?
| | Malocclusion | 1 | 2023 | 25 | 0.230 |
Why?
| | Mandibular Fractures | 1 | 2023 | 11 | 0.230 |
Why?
| | Insurance | 1 | 2023 | 11 | 0.230 |
Why?
| | Sezary Syndrome | 1 | 2023 | 44 | 0.230 |
Why?
| | Skull Fractures | 1 | 2023 | 30 | 0.230 |
Why?
| | Mycosis Fungoides | 1 | 2023 | 62 | 0.230 |
Why?
| | Pain, Postoperative | 3 | 2023 | 211 | 0.230 |
Why?
| | Hindlimb | 2 | 2003 | 137 | 0.230 |
Why?
| | Weight Loss | 1 | 2008 | 655 | 0.220 |
Why?
| | Treatment Outcome | 10 | 2019 | 9342 | 0.220 |
Why?
| | Seroma | 1 | 2022 | 4 | 0.220 |
Why?
| | Interleukin-2 | 2 | 2023 | 416 | 0.220 |
Why?
| | Adult | 11 | 2021 | 31512 | 0.220 |
Why?
| | Extremities | 2 | 2002 | 113 | 0.210 |
Why?
| | Incidental Findings | 1 | 2022 | 80 | 0.210 |
Why?
| | Cyclosporine | 3 | 2016 | 173 | 0.200 |
Why?
| | Body Mass Index | 1 | 2008 | 2092 | 0.190 |
Why?
| | Hypotension | 1 | 2022 | 120 | 0.190 |
Why?
| | Epidermal Growth Factor | 1 | 2021 | 173 | 0.190 |
Why?
| | Magnetic Resonance Imaging | 1 | 2011 | 3174 | 0.180 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2014 | 359 | 0.180 |
Why?
| | Flow Cytometry | 4 | 2020 | 1085 | 0.180 |
Why?
| | Bone Transplantation | 1 | 2001 | 99 | 0.180 |
Why?
| | United States | 7 | 2023 | 12555 | 0.180 |
Why?
| | Time Factors | 6 | 2014 | 6412 | 0.180 |
Why?
| | Venous Thromboembolism | 1 | 2023 | 234 | 0.180 |
Why?
| | Abdomen | 2 | 2010 | 110 | 0.170 |
Why?
| | Keloid | 1 | 2019 | 7 | 0.170 |
Why?
| | Antigens | 2 | 2016 | 320 | 0.170 |
Why?
| | Analgesics, Opioid | 2 | 2023 | 794 | 0.170 |
Why?
| | Dermis | 1 | 2019 | 29 | 0.170 |
Why?
| | Postoperative Period | 2 | 2023 | 309 | 0.170 |
Why?
| | Reoperation | 2 | 2017 | 557 | 0.160 |
Why?
| | Tattooing | 1 | 2018 | 10 | 0.160 |
Why?
| | Fluorouracil | 1 | 2019 | 151 | 0.160 |
Why?
| | Indocyanine Green | 2 | 2022 | 13 | 0.160 |
Why?
| | Chimera | 2 | 2011 | 60 | 0.150 |
Why?
| | Data Collection | 2 | 2011 | 658 | 0.150 |
Why?
| | Graft vs Host Disease | 2 | 2016 | 216 | 0.150 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2017 | 91 | 0.150 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2016 | 70 | 0.140 |
Why?
| | Length of Stay | 1 | 2021 | 1032 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 2 | 2010 | 499 | 0.140 |
Why?
| | Mycophenolic Acid | 1 | 2016 | 79 | 0.140 |
Why?
| | Hernia, Ventral | 1 | 2016 | 19 | 0.140 |
Why?
| | Opioid-Related Disorders | 1 | 2023 | 417 | 0.140 |
Why?
| | Bupivacaine | 1 | 2016 | 34 | 0.140 |
Why?
| | Prospective Studies | 3 | 2021 | 6471 | 0.140 |
Why?
| | Surgical Mesh | 1 | 2016 | 41 | 0.140 |
Why?
| | Herniorrhaphy | 1 | 2016 | 52 | 0.140 |
Why?
| | Muscle, Skeletal | 2 | 2006 | 1515 | 0.140 |
Why?
| | Leukocytes | 1 | 2016 | 290 | 0.130 |
Why?
| | Whole-Body Irradiation | 2 | 2012 | 72 | 0.130 |
Why?
| | Lymphocyte Culture Test, Mixed | 1 | 2014 | 46 | 0.130 |
Why?
| | Myeloablative Agonists | 1 | 2014 | 22 | 0.130 |
Why?
| | Cadaver | 2 | 2010 | 327 | 0.120 |
Why?
| | False Negative Reactions | 1 | 2014 | 57 | 0.120 |
Why?
| | Patient Selection | 2 | 2008 | 676 | 0.120 |
Why?
| | CD3 Complex | 1 | 2014 | 92 | 0.120 |
Why?
| | False Positive Reactions | 1 | 2014 | 115 | 0.120 |
Why?
| | Dissection | 1 | 2014 | 55 | 0.120 |
Why?
| | Multivariate Analysis | 3 | 2016 | 1474 | 0.120 |
Why?
| | Temporal Arteries | 1 | 2014 | 47 | 0.120 |
Why?
| | Surveys and Questionnaires | 2 | 2020 | 4708 | 0.120 |
Why?
| | Allografts | 1 | 2014 | 135 | 0.120 |
Why?
| | Histocompatibility Antigens | 1 | 2014 | 102 | 0.120 |
Why?
| | Random Allocation | 1 | 2014 | 344 | 0.120 |
Why?
| | Risk Assessment | 2 | 2014 | 3057 | 0.120 |
Why?
| | Forkhead Transcription Factors | 1 | 2014 | 182 | 0.120 |
Why?
| | Pain Management | 1 | 2016 | 294 | 0.110 |
Why?
| | Prosthesis Failure | 1 | 2014 | 120 | 0.110 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 27 | 0.110 |
Why?
| | Health Care Costs | 1 | 2016 | 394 | 0.110 |
Why?
| | Prostheses and Implants | 1 | 2014 | 141 | 0.110 |
Why?
| | Recurrence | 2 | 2019 | 975 | 0.110 |
Why?
| | Regional Blood Flow | 1 | 2014 | 418 | 0.110 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 1974 | 0.100 |
Why?
| | Paternalism | 1 | 2011 | 4 | 0.100 |
Why?
| | Monitoring, Physiologic | 1 | 2014 | 271 | 0.100 |
Why?
| | Collagen | 1 | 2014 | 433 | 0.100 |
Why?
| | Beneficence | 1 | 2011 | 18 | 0.100 |
Why?
| | Hematopoiesis | 1 | 2012 | 175 | 0.100 |
Why?
| | Marketing of Health Services | 1 | 2011 | 15 | 0.100 |
Why?
| | Intraoperative Care | 1 | 2011 | 39 | 0.100 |
Why?
| | Personal Autonomy | 1 | 2011 | 41 | 0.100 |
Why?
| | Ethics, Medical | 1 | 2011 | 73 | 0.100 |
Why?
| | Disease Models, Animal | 3 | 2014 | 3730 | 0.100 |
Why?
| | Professional Practice | 1 | 2011 | 62 | 0.100 |
Why?
| | Treatment Failure | 1 | 2012 | 341 | 0.100 |
Why?
| | Aged | 6 | 2017 | 19657 | 0.100 |
Why?
| | Informed Consent | 1 | 2011 | 163 | 0.090 |
Why?
| | Suture Techniques | 1 | 2011 | 134 | 0.090 |
Why?
| | Neovascularization, Physiologic | 1 | 2011 | 181 | 0.090 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2010 | 35 | 0.090 |
Why?
| | Radiography, Abdominal | 1 | 2010 | 32 | 0.090 |
Why?
| | Nutrition Assessment | 1 | 2010 | 78 | 0.090 |
Why?
| | Sensitivity and Specificity | 1 | 2014 | 1795 | 0.090 |
Why?
| | Logistic Models | 2 | 2016 | 1901 | 0.090 |
Why?
| | Practice Guidelines as Topic | 1 | 2017 | 1440 | 0.090 |
Why?
| | Male | 8 | 2016 | 57801 | 0.090 |
Why?
| | Transplantation, Autologous | 1 | 2010 | 191 | 0.090 |
Why?
| | Risk Factors | 4 | 2023 | 9000 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2016 | 2874 | 0.090 |
Why?
| | Organ Transplantation | 1 | 2011 | 165 | 0.080 |
Why?
| | North America | 1 | 2009 | 266 | 0.080 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2021 | 740 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 653 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2011 | 693 | 0.070 |
Why?
| | Spinal Cord Injuries | 1 | 2010 | 184 | 0.070 |
Why?
| | Diagnostic Imaging | 1 | 2009 | 294 | 0.070 |
Why?
| | Health Care Surveys | 1 | 2009 | 546 | 0.070 |
Why?
| | Back Injuries | 1 | 2006 | 5 | 0.070 |
Why?
| | Omentum | 1 | 2006 | 11 | 0.070 |
Why?
| | Head and Neck Neoplasms | 1 | 2012 | 471 | 0.070 |
Why?
| | Cytokines | 1 | 2014 | 1900 | 0.070 |
Why?
| | Debridement | 1 | 2006 | 79 | 0.070 |
Why?
| | Case Management | 1 | 2006 | 63 | 0.070 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2012 | 900 | 0.070 |
Why?
| | Linear Models | 1 | 2008 | 827 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2008 | 1293 | 0.070 |
Why?
| | Burns | 1 | 2009 | 247 | 0.070 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 1868 | 0.070 |
Why?
| | Melanoma | 1 | 2012 | 664 | 0.060 |
Why?
| | Antibodies, Monoclonal | 2 | 2023 | 1284 | 0.060 |
Why?
| | Major Histocompatibility Complex | 1 | 2005 | 220 | 0.060 |
Why?
| | Biomarkers | 1 | 2014 | 3588 | 0.060 |
Why?
| | Hydrocodone | 1 | 2023 | 15 | 0.060 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1094 | 0.060 |
Why?
| | Tobacco Use | 1 | 2023 | 58 | 0.060 |
Why?
| | Tissue Donors | 1 | 2005 | 336 | 0.060 |
Why?
| | Mandible | 1 | 2023 | 65 | 0.060 |
Why?
| | Chemoprevention | 1 | 2023 | 89 | 0.060 |
Why?
| | Physicians | 1 | 2011 | 794 | 0.050 |
Why?
| | Pregnancy | 1 | 2014 | 5690 | 0.050 |
Why?
| | Perfusion | 1 | 2022 | 153 | 0.050 |
Why?
| | Umbilicus | 1 | 2022 | 15 | 0.050 |
Why?
| | Transplantation Immunology | 1 | 2002 | 31 | 0.050 |
Why?
| | Peripheral Nerves | 1 | 2002 | 65 | 0.050 |
Why?
| | Cicatrix | 1 | 2022 | 53 | 0.050 |
Why?
| | Insurance, Health | 1 | 2023 | 244 | 0.050 |
Why?
| | Erlotinib Hydrochloride | 1 | 2021 | 66 | 0.050 |
Why?
| | Mice | 3 | 2023 | 15520 | 0.050 |
Why?
| | Quality of Life | 1 | 2011 | 2366 | 0.050 |
Why?
| | Lymphocyte Depletion | 1 | 2001 | 119 | 0.050 |
Why?
| | Outpatients | 1 | 2023 | 325 | 0.050 |
Why?
| | Musculoskeletal System | 1 | 2001 | 55 | 0.050 |
Why?
| | Receptors, CCR4 | 1 | 2020 | 16 | 0.050 |
Why?
| | Physical Therapy Modalities | 1 | 2023 | 274 | 0.050 |
Why?
| | Mice, SCID | 1 | 2021 | 333 | 0.050 |
Why?
| | Inhibitory Concentration 50 | 1 | 2020 | 81 | 0.050 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2020 | 71 | 0.050 |
Why?
| | Forelimb | 1 | 1999 | 29 | 0.040 |
Why?
| | Histocompatibility Testing | 1 | 2000 | 123 | 0.040 |
Why?
| | Dopamine | 1 | 2022 | 249 | 0.040 |
Why?
| | Veterans | 1 | 2010 | 1208 | 0.040 |
Why?
| | Lymphocytes | 1 | 2001 | 347 | 0.040 |
Why?
| | Injections, Intralesional | 1 | 2019 | 33 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 574 | 0.040 |
Why?
| | Immunity, Cellular | 1 | 2001 | 270 | 0.040 |
Why?
| | Anticoagulants | 1 | 2023 | 559 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2019 | 126 | 0.040 |
Why?
| | Tacrolimus | 1 | 1999 | 151 | 0.040 |
Why?
| | Skin | 1 | 2003 | 657 | 0.040 |
Why?
| | Margins of Excision | 1 | 2017 | 31 | 0.040 |
Why?
| | Patient Acceptance of Health Care | 1 | 2023 | 687 | 0.040 |
Why?
| | Carcinoma, Lobular | 1 | 2017 | 56 | 0.040 |
Why?
| | Phosphoproteins | 1 | 2019 | 308 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2020 | 1308 | 0.040 |
Why?
| | Narcotics | 1 | 2016 | 50 | 0.030 |
Why?
| | Cost Savings | 1 | 2016 | 77 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 394 | 0.030 |
Why?
| | Anesthetics, Local | 1 | 2016 | 85 | 0.030 |
Why?
| | Nerve Block | 1 | 2016 | 67 | 0.030 |
Why?
| | Consensus | 1 | 2017 | 534 | 0.030 |
Why?
| | Biopsy | 1 | 2019 | 1079 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2021 | 811 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2017 | 295 | 0.030 |
Why?
| | Tissue Expansion Devices | 1 | 2014 | 3 | 0.030 |
Why?
| | Tissue Expansion | 1 | 2014 | 6 | 0.030 |
Why?
| | Models, Statistical | 1 | 2018 | 636 | 0.030 |
Why?
| | Cellulitis | 1 | 2014 | 47 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 2851 | 0.030 |
Why?
| | Equipment Failure Analysis | 1 | 2014 | 139 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2016 | 554 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2017 | 523 | 0.030 |
Why?
| | Leukocyte Transfusion | 1 | 2012 | 4 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4552 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1597 | 0.030 |
Why?
| | Wound Healing | 1 | 2014 | 270 | 0.030 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2012 | 177 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2013 | 6561 | 0.020 |
Why?
| | Fluorescence | 1 | 2011 | 159 | 0.020 |
Why?
| | Transcription Factors | 1 | 2019 | 1570 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2013 | 749 | 0.020 |
Why?
| | Equipment Design | 1 | 2011 | 519 | 0.020 |
Why?
| | Comorbidity | 1 | 2014 | 1527 | 0.020 |
Why?
| | Colorado | 1 | 2017 | 4196 | 0.020 |
Why?
| | Incidence | 1 | 2014 | 2424 | 0.020 |
Why?
| | Young Adult | 2 | 2013 | 10793 | 0.020 |
Why?
| | Smoking | 1 | 2014 | 1487 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2014 | 942 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2004 | 208 | 0.010 |
Why?
| | Obesity | 1 | 2014 | 2746 | 0.010 |
Why?
| | Antigens, Surface | 1 | 2001 | 156 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2004 | 1774 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2004 | 4077 | 0.010 |
Why?
| | Adolescent | 1 | 2012 | 18480 | 0.010 |
Why?
|
|
Mathes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|